Overview
Work History
Education
Skills
Certification
Awards
Publications
Timeline
Generic

Ahmed I. Elhemaly

Professor of Pediatric Hematology/Oncology
Cairo

Overview

22
22
years of professional experience
1
1
Certification

Work History

PI

CCHE site
03.2023
  • Member of the PNOC (Pediatric Neurooncology consortium) and as accredited member in the PNOC

CO/PI of BMT and Neuroncology study team

Children cancer hospital Egypt
01.2022 - Current

Professor of Pediatric Hematology and Oncology

National Cancer Institute, Cairo University
01.2019 - Current

Consultant of bone marrow transplantation

Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2014 - Current
  • Member of the bone marrow transplantation study team in CCHE

Consultant of Pediatric Hematology and Oncology

Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2013 - Current

Lecturer of Pediatric Hematology and Oncology

National Cancer Institute, Cairo University
01.2013 - 01.2020

Attending of Pediatric Hematology and Oncology

National Cancer Institute, Cairo University
01.2008 - 01.2012

Attending of Pediatric Hematology and Oncology

Children’s Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2008 - 01.2012

Internship

Cairo University Hospitals
01.2004 - 01.2005

Education

Doctorate degree of Science (DSc) - Pediatric Hematology/Oncology

Cairo University
01.2013

Masters - Pediatric Oncology

Cairo University
01.2008

Bachelor of Medicine & Surgery (M. B., B. Ch.) - Medicine

Cairo University
01.2003

Skills

  • Low grade glioma trials using targeted therapy

  • Using autologous bone marrow transplant in pediatric brain tumors especially infantile medulloblastoma

  • Allo transplant in haematology malignancies

Certification

2003-present Egyptian Ministry of Health and Population: Unrestricted medical license number 14312

Awards

1997-2003 Dean’s Honor List: Kasr El-Aini School of Medicine: Cairo University, Cairo, Egypt., 2003 Medical Doctoral Degree Graduation Honor of Excellence: Faculty of Medicine, Cairo University, Cairo, Egypt., 2008 Masters Degree Honor of Excellence: Children’s Hospital, Cairo University, Cairo, Egypt., 2013 Doctorate degree of Science (DSc) in Pediatric Hematology/Oncology; Cairo University, Cairo, Egypt.

Publications

  • BONE MARROW ABLATIVE CHEMOTHERAPY ASSOCIATED WITH IMPROVED OUTCOMES AMONG PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS: Neur Oncology 25(Supplement_1):i34-i35 DOI:10.1093/neuoncology /noad073.136.
  • RARE-08. MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERMINOMA: Neuro-Oncology 25(Supplement_1):i35-i35:DOI:10.1093/neuoncology /noad073.137
  • Prognostic factors affecting infantile medulloblastoma outcomes in the molecular era: a 12-year single-center experience from Egypt : March 202 Future Oncology 19(1)DOI:10.2217/fon-2022-0559
  • Efficacy of different salvage regimens in progressive unresectable pediatric low-grade glioma September 2022,Oncology Letters 24(5) DOI:10.3892/ol.2022.13527
  • Palliative and end-of-life symptoms management for children with diffuse intrinsic pontine glioma: February 2022, Future Oncology 18(16),DOI:10.2217/fon-2021-1455
  • Prognostic factors and outcome of pineoblastoma: 10 years single-center experience: December 2021,Journal of the Egyptian National Cancer Institute 33(1),DOI:10.1186/s43046-021-00083-3
  • The Impact of Pretransplant Disease Characteristics on the Outcome of Autologous Stem Cell Transplantation for Neuroblastoma with High-Risk Features: A Retrospective Model from a Limited Resources Country: January 2019,Journal of Cancer Therapy 10(06):422-432 DOI:10.4236/jct.2019.106035
  • Association of Aggresomes with Survival Outcomes in Pediatric Medulloblastoma: August 2019, Scientific Reports 9(1)DOI:10.1038/s41598-019-49027-x
  • Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?: September 2018,Journal of Pediatric Hematology/Oncology 41(8),DOI:10.1097/MPH.0000000000001314
  • Risk stratification of pediatric high-grade glioma: a newly proposed prognostic score: December 2019,Child's Nervous System 35(12),DOI:10.1007/s00381-019-04257-2
  • Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma, Frontiers in Oncology 15,august 2025 DOI: 10.3389/fonc.2025.1537268
  • RARE-08. MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERMINOMA, Neur Oncology 25(Supplement_1):i34-i35 DOI:10.1093/neuoncology /noad073.136.
  • Does Salvage Chemotherapy Regimen Intensity Embark on Clearance of Bone Marrow Neuroblastoma?: May 2019: Asian Pacific Journal of Cancer Prevention 20(5):1519-1524 DOI:10.31557/APJCP.2019.20.5.1519

Timeline

PI

CCHE site
03.2023

CO/PI of BMT and Neuroncology study team

Children cancer hospital Egypt
01.2022 - Current

Professor of Pediatric Hematology and Oncology

National Cancer Institute, Cairo University
01.2019 - Current

Consultant of bone marrow transplantation

Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2014 - Current

Consultant of Pediatric Hematology and Oncology

Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2013 - Current

Lecturer of Pediatric Hematology and Oncology

National Cancer Institute, Cairo University
01.2013 - 01.2020

Attending of Pediatric Hematology and Oncology

National Cancer Institute, Cairo University
01.2008 - 01.2012

Attending of Pediatric Hematology and Oncology

Children’s Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2008 - 01.2012

Internship

Cairo University Hospitals
01.2004 - 01.2005

Bachelor of Medicine & Surgery (M. B., B. Ch.) - Medicine

Cairo University

Doctorate degree of Science (DSc) - Pediatric Hematology/Oncology

Cairo University

Masters - Pediatric Oncology

Cairo University
Ahmed I. ElhemalyProfessor of Pediatric Hematology/Oncology